Synedgen to Partner with the NIH for Radiation Countermeasures Product…

Synedgen Active Agent SY303A will undergo Further Non-Clinical Efficacy Testing at the Armed Forces Radiobiology Research Institute (AFRRI), in Bethesda, Maryland

(PRWeb November 14, 2012)

Read the full story at

Click here for reuse options!
Copyright 2012 Biotechblog

Comments are closed.

%d bloggers like this: